D1 Medical Technology Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

D1 Medical Technology General Information

Description

Developer and manufacturer of organoid technology intended to support regeneration medicine and transplantation. The company develops organoids to improve the development of disease diagnosis and treatment, new drug screening, and tumor marker identification, providing accurate, efficient and high-quality organoid models for new drug development and personalized treatments.

Contact Information

Website
www.d1med.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor
  • No. 665 Zhangjiang Road, China Pilot Free Trade Zone
  • Shanghai
  • China
+86 021
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 3rd Floor
  • No. 665 Zhangjiang Road, China Pilot Free Trade Zone
  • Shanghai
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

D1 Medical Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 19-Dec-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 14-Oct-2021 Completed Generating Revenue
1. Early Stage VC 08-Feb-2021 Completed Generating Revenue
To view D1 Medical Technology’s complete valuation and funding history, request access »

D1 Medical Technology Patents

D1 Medical Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024026676-A1 Preparation system and preparation method for vitroorganospheres with core-shell structure, and total system Inactive 02-Aug-2022
WO-2024027717-A1 Total system and method for full automatic preparation, sorting, and distribution and culturing of in-vitro organ microsphere Inactive 02-Aug-2022
WO-2023274338-A1 Culture medium, method, and reagent kit for rapidly culturing tumor organoids Inactive 01-Jul-2021
WO-2022241929-A1 Method for measuring maximum cross-sectional area of organoid, and application thereof Inactive 17-May-2021
WO-2022227289-A1 Method for detecting sensitivity of organoid to macromolecular drug with sandwich culture system Inactive 26-Apr-2021 G01N33/5011
To view D1 Medical Technology’s complete patent history, request access »

D1 Medical Technology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Zhejiang Huarui Holdings Growth/Expansion Minority
Delian Capital Venture Capital Minority
Kunnuo Tianqin Venture Capital Corporate Venture Capital Minority
Shanghai Guofang Fund of Funds Equity Investment Management Fund of Funds Minority
Co-Win Ventures Venture Capital Minority
To view D1 Medical Technology’s complete investors history, request access »

D1 Medical Technology FAQs

  • When was D1 Medical Technology founded?

    D1 Medical Technology was founded in 2019.

  • Where is D1 Medical Technology headquartered?

    D1 Medical Technology is headquartered in Shanghai, China.

  • What industry is D1 Medical Technology in?

    D1 Medical Technology’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is D1 Medical Technology a private or public company?

    D1 Medical Technology is a Private company.

  • What is D1 Medical Technology’s current revenue?

    The current revenue for D1 Medical Technology is .

  • How much funding has D1 Medical Technology raised over time?

    D1 Medical Technology has raised $18.6M.

  • Who are D1 Medical Technology’s investors?

    Zhejiang Huarui Holdings, Delian Capital, Kunnuo Tianqin Venture Capital, Shanghai Guofang Fund of Funds Equity Investment Management, and Co-Win Ventures have invested in D1 Medical Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process